ArticleChemistry & biodiversity2026
The Antimycobacterial Activity, Toxicity and Chemical Composition of South African Propolis.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Global research has explored the antimicrobial properties of propolis; however, the antimycobacterial activity of South African (SA) propolis has been neglected. This study evaluated 109 propolis samples collected from eight SA provinces where the antimycobacterial activity, chemical composition and toxicity was evaluated. Samples were tested using a broth microdilution assay against various Mycobacterium strains (M. fortuitum ATCC 6841, M. gordonae ATCC 14470 and M. smegmatis ATCC 14468) and the pathogenic M. tuberculosis H37Rv strain. A multi-step approach combining ultra-performance liquid chromatography/ mass spectrometry (UPLC-MS) profiling, high-performance thin-layer chromatography (HPTLC) bio-autography, brine shrimp toxicity testing and molecular docking was employed on eight bio-active and eight non-active propolis samples. Two samples (GP68 and EC77B) demonstrated promising activity, with MICs ranging from 49-195 µg/mL against non-tuberculous strains and 125 µg/mL against M. tuberculosis. Chemometric and bio-autography analyses identified flavonoids and related compounds, including pinocembrin, galangin, chrysin and pinobanksin compounds as major contributors to activity. Both samples were non-toxic at concentrations (1 mg/mL at 24 h; 0.5 mg/mL at 48 h). Molecular docking indicated favourable binding to key M. tuberculosis targets involved in cell wall biosynthesis (DprE1) and transcription (RNAP). This study demonstrates that selected SA-derived propolis samples show strong antimycobacterial potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.